Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The pathogenic role of the inflammasome in neurodegenerative diseases.
ZOCOR (simvastatin) Tablets
Progressive Increase of T1 Signal Intensity of the Dentate Nucleus on Unenhanced Magnetic Resonance Images Is Associated With Cumulative Doses of Intravenously Administered Gadodiamide in Patients With Normal Renal Function, Suggesting Dechelation.
Parkinsonism in multiple sclerosis patients: A casual or causal association?
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
CC3-03: Drug Characteristics Associated with Medication Adherence Across Eight Disease States.
Increased prevalence, incidence, and female predominance of multiple sclerosis in northern Japan.
Distinguishing Susac's syndrome from multiple sclerosis.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Helminth therapy or elimination: epidemiological, immunological, and clinical considerations.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE).
Growth arrest specific gene 6 protein concentration in cerebrospinal fluid correlates with relapse severity in multiple sclerosis.
Care of patients with multiple sclerosis.
A validated regulatory network for Th17 cell specification.
Decreased hydrocortisone sensitivity of T cell function in multiple sclerosis-associated major depression.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Mixed Panniculitis Secondary to Interferon beta-1a Therapy in a Woman With Multiple Sclerosis.
Fingolimod after natalizumab and the risk of short-term relapse.
Depression in multiple sclerosis: A long-term longitudinal study.
Human endogenous retroviruses and the nervous system.
Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin.
Delayed Central Nervous System Irradiation Effects in Rats - Part 2: Aggravation of Experimental Autoimmune Encephalomyelitis.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
Cell therapy for multiple sclerosis: an evolving concept with implications for other neurodegenerative diseases.
Pages
« first
‹ previous
…
266
267
268
269
270
271
272
273
274
…
next ›
last »